# BEVC

> BEVC is a VC fund in Berkeley backing Biotechnology, Medical and Biopharma. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Berkeley, United States
- Total investments: 5
- Last investment: Dec 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bevc/about/
- Website: https://www.bevc.com

BEVC is a VC fund in Berkeley focused on Biotechnology and Medical. BEVC invest in pioneers transforming cutting-edge science into disruptive companies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 80% |
| Medical | 2 | 40% |
| Biopharma | 2 | 40% |
| Life Science | 2 | 40% |
| Pharmaceutical | 2 | 40% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 60% |
| Series A | 2 | 40% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Addition Therapeutics | Addition Therapeutics focuses on developing RNA-only therapeutics using its proprietary PRINT technology. This approach enables the precise insertion of genetic elements at specific safe harbor sites, aiming to transform the field of genetic medicine. They operate within the biotechnology industry and are backed by venture capital. Their innovativemethods target gene editing and regulation, potentially offering new solutions in the field of genetic therapies. | $100M | Series A | Dec 17, 2025 |  |
| Montara Therapeutics | Montara Therapeutics is a biotechnology company. | $20M | Seed | Mar 13, 2025 |  |
| PinkDx | PinkDx is a biotechnology company. | $5M | Series A | Jan 23, 2025 |  |
| Radar Therapeutics | Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics. | $13.4M | Seed | May 23, 2024 |  |
| Insamo | Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides which lies in its automated process of designing, synthesizing, and testing at an unprecedented scale. | $12M | Seed | Feb 21, 2024 |  |

5 of 5 investments shown.

## Co-investors
- [Two Bear Capital](https://shizune.co/investors/profile/two-bear-capital) — VC Fund, 3 deals together
- [KdT Ventures](https://shizune.co/investors/profile/kdt-ventures) — VC Fund, 2 deals together
- [Pivotal Life Sciences](https://shizune.co/investors/profile/pivotal-life-sciences) — VC Fund, 2 deals together
- [SR One](https://shizune.co/investors/profile/sr-one) — VC Fund, 2 deals together
- [Abingworth](https://shizune.co/investors/profile/abingworth-management) — VC Fund, 1 deal together
- [Axial VC](https://shizune.co/investors/profile/axial-vc) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does BEVC invest in?

BEVC invests primarily in Biotechnology, Medical and Biopharma startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did BEVC last invest?

The most recent investment recorded for BEVC closed in Dec 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co